We are seeking a high-energy MBA1 to join Teiko this summer, build a new business in biopharma and receive individualized mentorship from our proven entrepreneurial and scientific team.
We started Teiko Bio to use immune insights to help deliver life changing therapies to those who need them most. Today, Teiko delivers on its mission by supporting therapy development and informing clinical decision-making. By using cutting edge mass cytometry, Teiko’s leading assay, the TokuProfile, maps characteristics of response, accelerates clinical pipeline candidates, and supports the identification of novel discoveries.
Some of the largest immunotherapy companies in the world are now using Teiko to analyze the immune response of drug candidates in their pipeline.
We are seeking a high-energy MBA1 to join Teiko this summer, build a new business in biopharma and receive individualized mentorship from our proven entrepreneurial and scientific team.
About you:
Responsibilities
Experience